Swiss National Bank Portfolio holdings
The Swiss National Bank (SNB), founded in 1907 and headquartered in Zurich with an office in Bern, is Switzerland’s central bank, responsible for conducting monetary policy, issuing the Swiss franc, and ensuring price stability, while uniquely managing a massive investment portfolio. Unlike most central banks, the SNB is a joint-stock company with shares traded on the SIX Swiss Exchange, owned roughly 55% by public entities like cantons and 45% by private investors, yet it operates independently under federal oversight. It holds over $800 billion in foreign currency reserves as of late 2024—invested in global equities, bonds, and gold—to manage the franc’s value, famously intervening in markets to prevent excessive appreciation, as seen with the 2015 abandonment of the euro peg. Led by Chairman Thomas Jordan until his planned exit in September 2024, the SNB balances its dual role as a monetary authority and a significant global investor, influencing both Swiss and international financial stability.
Top Buys
| 1 |
NextEra Energy, Inc.
NEE
|
$514M |
| 2 |
McCormick & Company Non-Voting
MKC
|
$81.8M |
| 3 |
NetEase
NTES
|
$79M |
| 4 |
Viatris
VTRS
|
$53.9M |
| 5 |
Pinduoduo
PDD
|
$46.6M |
Top Sells
| 1 |
Apple
AAPL
|
$385M |
| 2 |
Microsoft
MSFT
|
$198M |
| 3 |
Amazon
AMZN
|
$138M |
| 4 |
VER
VEREIT, Inc.
VER
|
$128M |
| 5 |
Alphabet (Google) Class C
GOOG
|
$76.7M |
Sector Composition
| 1 | Technology | 26.42% |
| 2 | Healthcare | 14.37% |
| 3 | Consumer Discretionary | 13.81% |
| 4 | Communication Services | 10.63% |
| 5 | Industrials | 8.55% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
AT&T
T
$209B
| $838M | 0.6% | 29,154,937 -779,900 | -3% | -$22.4M |
|
27
Pfizer
PFE
$141B
| $828M | 0.59% | 22,495,391 -605,600 | -3% | -$22.3M |
|
28
Intel
INTC
$107B
| $800M | 0.57% | 16,059,704 -421,100 | -3% | -$21M |
|
29
Salesforce
CRM
$245B
| $765M | 0.54% | 3,436,242 -64,700 | -2% | -$14.4M |
|
30
Abbott
ABT
$231B
| $757M | 0.54% | 6,913,108 -194,500 | -3% | -$21.3M |
|
31
Cisco
CSCO
$274B
| $749M | 0.53% | 16,729,445 -475,100 | -3% | -$21.3M |
|
32
McDonald's
MCD
$224B
| $743M | 0.53% | 3,461,482 -70,300 | -2% | -$15.1M |
|
33
Accenture
ACN
$162B
| $729M | 0.52% | 2,789,538 -68,700 | -2% | -$17.9M |
|
34
AbbVie
ABBV
$372B
| $714M | 0.51% | 6,664,191 -210,700 | -3% | -$22.6M |
|
35
Thermo Fisher Scientific
TMO
$186B
| $696M | 0.49% | 1,493,860 -43,600 | -3% | -$20.3M |
|
|
36
NextEra Energy, Inc.
NEE
$148B
| $690M | 0.49% | 8,939,932 +6,657,349 | +292% | +$514M |
|
37
Exxon Mobil
XOM
$487B
| $674M | 0.48% | 16,344,692 -762,300 | -4% | -$31.4M |
|
38
Broadcom
AVGO
$1.4T
| $672M | 0.48% | 1,535,213 -37,300 | -2% | -$16.3M |
|
39
Medtronic
MDT
$119B
| $668M | 0.48% | 5,706,554 -133,800 | -2% | -$15.7M |
|
40
Nike
NKE
$114B
| $665M | 0.47% | 4,701,161 -125,600 | -3% | -$17.8M |
|
41
Costco
COST
$418B
| $650M | 0.46% | 1,725,918 -50,100 | -3% | -$18.9M |
|
42
Qualcomm
QCOM
$173B
| $649M | 0.46% | 4,260,407 -118,400 | -3% | -$18M |
|
43
Eli Lilly
LLY
$657B
| $642M | 0.46% | 3,799,498 -90,000 | -2% | -$15.2M |
|
44
Chevron
CVX
$324B
| $616M | 0.44% | 7,298,640 +390 | +0% | +$32.9K |
|
45
Danaher
DHR
$147B
| $611M | 0.43% | 2,749,920 -63,600 | -2% | -$14.1M |
|
46
Texas Instruments
TXN
$184B
| $585M | 0.42% | 3,565,054 -111,600 | -3% | -$18.3M |
|
47
Honeywell
HON
$139B
| $564M | 0.4% | 2,650,034 -81,800 | -3% | -$17.4M |
|
48
Linde
LIN
$224B
| $558M | 0.4% | 2,117,143 -57,500 | -3% | -$15.2M |
|
49
Starbucks
SBUX
$100B
| $537M | 0.38% | 5,015,027 -119,300 | -2% | -$12.8M |
|
50
Bristol-Myers Squibb
BMY
$96B
| $535M | 0.38% | 8,623,388 -293,700 | -3% | -$18.2M |
|